跳至主要内容
临床试验/CTRI/2024/11/077007
CTRI/2024/11/077007已完成Phase 3 4

Comparison of Ultrasound Guided Interscalene Brachial Plexus Block with 6ml and 10ml of 0.25 percent Ropivacaine for post operative analgesia in elective upper limb orthopaedic surgeries: A Randomised Controlled Trial

NKP Salve Institute of Medical Sciences and Research Centre and Lata Mangeshkar Hospital1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2024年12月1日最近更新:

试验速览

阶段
Phase 3 4
状态
已完成
发起方
入组人数
80
试验地点
1
主要终点
To compare post operative analgesia between 6 ml of 0.25% Ropivacaine

研究概览

简要总结

In the field of Anaesthesia, regional blocks are growing popular these

days because of prolonged duration of action and lesser perioperative

analgesic requirement.

• Interscalene brachial plexus block is frequently used to provide

perioperative analgesia to patients undergoing upper limb surgeries to

optimise recovery, decrease opioid consumption and reduce the

hospital stay.

• Ropivacaine is a long-acting amide local anaesthetic agent that is

structurally related to Bupivacaine.

• It is a pure S(-)enantiomer, unlike Bupivacaine, which is a racemate,

developed for the purpose of reducing potential toxicity and improving

relative sensory and motor block profiles .

• Ropivacaine in interscalene brachial plexus block provides safe and

effective pain relief , decreased incidence of side effects and better

patient satisfaction than with opioids given intravenously.

• The use of a local anaesthetic with a lower concentration and volume

results in fewer instances of side effects brought on by local anaesthetic

drugs.

• Furthermore, use of ultrasound in peripheral nerve block has reduced

the amount of Local Anaesthetic.

• Studies have been found with 0.5% or 0.75% of 15ml Ropivacaine used

for peripheral blocks which provide same analgesia with less side effects

of Ropivacaine .

• Interscalene brachial plexus block is generally performed on patients

undergoing shoulder, upper arm and elbow surgeries .

• One of the side effects of this block is Hemidiaphragmatic paresis.

• Studies were found where small volume of local anaesthetic for

interscalene brachial plexus block helped in reducing the incidence of

hemidiaphragmatic paresis.

• Therefore, our aim is to compare 6ml and 10ml of 0.25% Ropivacaine in

ultrasound guided interscalene block in upper limb surgeries with

respect to postoperative analgesia and side effects like

hemidiaphragmatic paresis.

研究设计

研究类型
Interventional
分配方式
Other
盲法
Participant and Outcome Assessor Blinded

入排标准

年龄范围
18.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • 1.Patients posted for upper limb orthopaedic surgeries 2.Patients in ASA criteria 1,2 3.Patients with BMI less than 30 kg/m2.

排除标准

  • History of allergy to study drug
  • Patient with coagulation disorders
  • Infection at site of block
  • Severe bronchopulmonary disease
  • Neurological deficit in the operating arm 6.

结局指标

主要结局

To compare post operative analgesia between 6 ml of 0.25% Ropivacaine

时间窗: 1. Total analgesic dose required in 24 hours after block. | 2. Numerical rating scale (NRS) for pain assessment at 0.5, 1, 1.5, 2, 4, 6, 12, 24 hrs after block in first 24 hours. | 3. Time for requirement for first rescue analgesia after block in first 24 hours.

vs 10 ml of 0.25% Ropivacaine in ultrasound (USG) guided Interscalene

时间窗: 1. Total analgesic dose required in 24 hours after block. | 2. Numerical rating scale (NRS) for pain assessment at 0.5, 1, 1.5, 2, 4, 6, 12, 24 hrs after block in first 24 hours. | 3. Time for requirement for first rescue analgesia after block in first 24 hours.

brachial plexus block for Elective Upper Limb Orthopedic surgeries

时间窗: 1. Total analgesic dose required in 24 hours after block. | 2. Numerical rating scale (NRS) for pain assessment at 0.5, 1, 1.5, 2, 4, 6, 12, 24 hrs after block in first 24 hours. | 3. Time for requirement for first rescue analgesia after block in first 24 hours.

次要结局

  • To compare side effects of 0.25 percent Ropivacaine 6 ml & 0.25 percent(Ropivacaine 10 ml in Ultrasound guided Interscalene Block for Upper)

研究者

发起方
NKP Salve Institute of Medical Sciences and Research Centre and Lata Mangeshkar Hospital
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Gayatri Awatade

N.K.P Salve Institute of Medical Sciences and Research Centre and Lata Mangeshkar Hospital

研究点 (1)

Loading locations...

相似试验